(S (NP (ADJP (JJ Mild) (JJ cognitive)) (NN impairment) (PRN (-LRB- -LRB-) (NP (NNP MCI)) (-RRB- -RRB-))) (VP (VBZ is) (NP (NP (DT a) (JJ prodromal) (NN phase)) (PP (IN in) (NP (NP (DT the) (NN progression)) (PP (IN from) (NP (NP (JJ normal) (NN aging)) (PP (IN to) (NP (NP (NN dementia)) (, ,) (NP (NP (RB especially) (NNPS Alzheimers)) (NP (NN disease))))))))))) (. .))
(S (SBAR (RB Even) (IN though) (S (NP (EX there)) (VP (VBZ is) (NP (NP (JJ mild) (JJ cognitive) (NN decline)) (PP (IN in) (NP (NNP MCI) (NNS patients))))))) (, ,) (NP (PRP they)) (VP (VP (VBP have) (NP (ADJP (JJ normal) (RB overall)) (NN cognition))) (CC and) (ADVP (RB thus)) (VP (VBZ is) (VP (VBG challenging) (S (VP (TO to) (VP (VB distinguish) (PP (IN from) (NP (JJ normal) (NN aging))))))))) (. .))
(S (S (VP (VP (VBG Using) (NP (NP (VBN transcribed) (NNS data)) (VP (VBN obtained) (PP (IN from) (NP (NP (VBN recorded) (JJ conversational) (NNS interactions)) (PP (IN between) (NP (NP (NNS participants)) (CC and) (NP (VBN trained) (NNS interviewers))))))))) (, ,) (CC and) (VP (VBG applying) (NP (JJ supervised) (NN learning) (NNS models)) (PP (IN to) (NP (DT these) (NNS data)))))) (, ,) (NP (DT a) (JJ recent) (JJ clinical) (NN trial)) (VP (VBZ has) (VP (VBN shown) (NP (DT a) (JJ promising) (NN result)) (PP (IN in) (S (VP (VBG differentiating) (NP (NNP MCI)) (PP (IN from) (NP (JJ normal) (NN aging)))))))) (. .))
(S (ADVP (RB However)) (, ,) (NP (NP (DT the) (JJ substantial) (NN amount)) (PP (IN of) (NP (NP (NNS interactions)) (PP (IN with) (NP (JJ medical) (NN staff)))))) (VP (MD can) (ADVP (RB still)) (VP (VB incur) (NP (JJ significant) (NML (JJ medical) (NN care)) (NNS expenses)) (PP (IN in) (NP (NN practice))))) (. .))
(S (PP (IN In) (NP (DT this) (NN paper))) (, ,) (NP (PRP we)) (VP (VBP propose) (NP (DT a) (JJ novel) (NML (NML (NN reinforcement) (NN learning)) (-LRB- -LRB-) (NML (NN RL)) (-RRB- -RRB-)) (NN framework)) (S (VP (TO to) (VP (VB train) (NP (DT an) (JJ efficient) (NN dialogue) (NN agent)) (PP (IN on) (NP (NP (VBG existing) (NNS transcripts)) (PP (IN from) (NP (JJ clinical) (NNS trials))))))))) (. .))
(S (ADVP (RB Specifically)) (, ,) (NP (DT the) (NN agent)) (VP (VP (VBZ is) (VP (VBN trained) (S (VP (TO to) (VP (VB sketch) (NP (ADJP (NN disease) (HYPH -) (JJ specific)) (NP (JJ lexical) (NN probability) (NN distribution)))))))) (, ,) (CC and) (PP (ADVP (RB thus)) (IN to) (NP (NP (NN converse)) (PP (IN in) (NP (NP (DT a) (NN way)) (SBAR (WHNP (WDT that)) (S (VP (VP (VBZ maximizes) (NP (DT the) (NN diagnosis) (NN accuracy))) (CC and) (VP (VBZ minimizes) (NP (NP (DT the) (NN number)) (PP (IN of) (NP (NN conversation)))))))))))) (VP (VBZ turns))) (. .))
(S (NP (PRP We)) (VP (VBP evaluate) (NP (NP (DT the) (NN performance)) (PP (IN of) (NP (NP (DT the) (VBN proposed) (NN reinforcement)) (VP (VBG learning) (NP (NP (NN framework)) (PP (IN on) (NP (DT the) (NNP MCI) (NN diagnosis)))) (PP (IN from) (NP (DT a) (JJ real) (JJ clinical) (NN trial)))))))) (. .))
(S (NP (DT The) (NNS results)) (VP (VBP show) (SBAR (IN that) (S (SBAR (IN while) (S (S (VP (VBG using) (NP (NP (QP (RB only) (DT a) (JJ few)) (NNS turns)) (PP (IN of) (NP (NN conversation)))))) (, ,) (NP (PRP$ our) (NN framework)) (VP (MD can) (ADVP (RB significantly)) (VP (VB outperform) (NP (ADJP (NN state) (HYPH -) (IN of) (HYPH -) (DT the) (HYPH -) (NN art))))))) (VP (VBD supervised) (S (VP (VBG learning) (NP (NNS approaches)))))))) (. .))
